Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gallbladder disease and obesity].

Nahum Méndez-Sánchez1, Norberto C Chávez-Tapia, Misael Uribe

  • 1Departamento de Investigación Biomédica, Gastroenterología y Unidad de Hígado, Fundación Clínica Médica Sur, México DF, México. nmendez@medicasur.org.mx

Gaceta Medica De Mexico
|January 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast Cancer and Metabolic Dysfunction-Associated Steatotic Liver Disease.

International journal of molecular sciences·2026
Same author

Prevalence and Association of Liver Steatosis and Non-Alcoholic Pancreatic Steatosis in Very High Cardiovascular Risk.

Diseases (Basel, Switzerland)·2026
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease after Pancreatoduodenectomy: an Underestimated Metabolic Complication Driven by Unique Pathophysiological Mechanisms.

Journal of gastrointestinal cancer·2026
Same author

Bariatric Surgery in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: Long-Term Benefits for Liver Health.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Mini-Review: The Detoxification Effects of Black Radish in Metabolically Dysfunctional-Associated Fatty Liver Disease.

International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition·2026
Same author

Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond.

Journal of clinical and experimental hepatology·2025

Obesity significantly increases the risk of gallbladder disease, particularly gallstones. This review explores the epidemiological and pathophysiological links between obesity and gallstone formation.

Area of Science:

  • Gastroenterology and Hepatology
  • Metabolic Diseases
  • Epidemiology

Context:

  • Gallbladder disease represents a significant global health burden with substantial economic implications.
  • Obesity is a primary risk factor, driven by its increasing worldwide prevalence.
  • Gallbladder disease pathogenesis involves complex interactions between host and environmental factors.

Purpose:

  • To discuss the epidemiological factors linking obesity and gallstone disease.
  • To explore the pathophysiological mechanisms involved in gallstone formation in obese individuals.
  • To provide a comprehensive overview of obesity's role in gallbladder disease.

Summary:

  • Obesity is a major risk factor for gallstone disease, contributing to increased gallbladder cholesterol secretion.

Related Experiment Videos

  • Metabolic changes associated with obesity, alongside gallbladder motility disturbances, promote gallstone development.
  • This work reviews the epidemiological data and pathophysiological pathways connecting obesity and gallstones.

    • Impact:

    • Highlights the critical role of obesity in the development of common gallbladder conditions.
    • Informs public health strategies aimed at managing and preventing gallstone disease.
    • Provides a foundation for further research into obesity-related gallbladder pathophysiology.